To discover and develop innovative medicines from natural sources, especially from Brazil’s biomes, the Bioprospera® platform projects are highlights in innovation at Aché. The platform was structured to be sustainable and follows ESG principles when delivering therapeutic solutions to bring a better life to people and improved social development, thus creating value from biodiversity.
Since 2021 Aché has been part of a prospecting program in the Amazon region. The program was expanded in 2022 to identify potential projects in all Brazilian biomes. The results of this prospecting in 2023 will enable advances by Aché and startups in developing selected Amazonian technologies. A development from this initiative was the selection of nine technologies with the potential for use in future partnerships.
The Molecular Design and Synthesis Laboratory develops therapeutic solutions through research into new molecules that can revolutionize treatments Thousands of molecules have been synthesized for the Company’s different projects since 2015.
To stimulate the prospecting of partnerships with innovative companies, Aché has a hub of startups that develop projects that focus on solving challenges in the pharmaceutical segment.
Brazil has approximately 22% of the planet’s plant biodiversity, in addition to rich ethno-botanical knowledge. The Bioprospera® platform is based on ethnopharmacology and uses bioprospecting approaches to discover active natural molecules and extracts.